Pandemic products such as antiviral medicines, vaccines and diagnostics play a critical role in the control and treatment of pandemic influenza. During a pandemic, not all countries will have access to life-saving products. It is therefore of paramount importance to facilitate equitable access to pharmaceutical interventions for the largest number of countries in need.
Allocation and deployment of these products need to be carefully orchestrated to ensure that they are sent in a timely manner to the places where they are most needed and where they can be used efficiently and expeditiously. This will be a barometer of success for a global pandemic response.
Collaboration and coordination
WHO collaboration and coordination activities towards ensuring equitable access and allocation of pandemic influenza products at global level
WHO is engaging in a series of activities to ensure availability and equitable access and allocation of pandemic influenza products including vaccines, at a global level.
Such activities entail exercising planning, coordination and allocation mechanisms of pandemic influenza products.
By employing simulation and gaming exercises involving numerous types of stakeholders, WHO is facilitating identification of gaps, bottlenecks and areas of improvement in strategic and operational plans.
- Global survey on National Vaccine Deployment and Vaccination Plans for pandemic A(H1N1) 2009 vaccine – 2010 Report of Findings
- Main operational lessons learnt from the WHO Pandemic Influenza A(H1N1) Vaccine Deployment Initiative Report of a WHO Meeting held in Geneva, Switzerland, 13–15 December 2010
- Report of the WHO Pandemic Influenza A(H1N1) Vaccine Deployment Initiative
National Deployment Planning activities and resources
Developing and updating a National Deployment and Vaccination Plan for Pandemic Influenza Vaccines (NDVP)
During a pandemic, countries may benefit from internal vaccine producing capacity, may have established advance purchase agreements with manufacturers from different countries or may rely solely on the stockpiles of pandemic influenza vaccines reserved for WHO. The existence of national deployment and vaccination plans for pandemic influenza vaccines will be a pre-requisite in the request process to access vaccines from WHO secured stockpiles.
Regardless of internal vaccine producing capacities or need to access WHO reserved vaccine doses, each country should have a plan for national deployment and vaccination. Preparedness activities in this respect would represent an important foundation for an effective and efficient pandemic influenza deployment response, which should be reflected in successful vaccination of the target population with no vaccine wastage and optimal operational efficiency.
– Guidance on Development and Implementation of a National Deployment and Vaccination Plan for Pandemic Influenza Vaccines
– Checklist on Development and Implementation of a National Deployment and Vaccination Plan for Pandemic Influenza Vaccines
Open WHO Course
WHO has developed an OpenWHO course to provide a concise and easily accessible overview of planning considerations for countries to develop and update their national deployment and vaccination plans on the use and deployment of pandemic influenza vaccines.
Please watch the below video for more details on the importance of these type of activities and follow the link to access the OpenWHO course.
PIP Planning for Deployment
World Health Organization
Avenue Appia 20
1211 Geneva 27